Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Inflammatory Bowel Diseases|August 22, 2013
Efficacy and safety of natalizumab in Crohn's disease patients treated at 6 Boston academic hospitalsPascal Juillerat, Sharmeel K Wasan, Sharyle A Fowler, et al.
Cell|May 25, 2024
Gut bacteria convert glucocorticoids into progestins in the presence of hydrogen gasMegan D McCurry, Gabriel D D'Agostino, Jasmine T Walsh, et al.
Environmental Research|October 6, 2017
A crossover-crossback prospective study of dibutyl-phthalate exposure from mesalamine medications and serum reproductive hormones in menFeiby L Nassan, Brent A Coull, Niels E Skakkebaek, et al.
Plos One|July 7, 2012
Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel diseaseEliseo Papa, Michael Docktor, Christopher Smillie, et al.
Alimentary Pharmacology & Therapeutics|August 12, 2024
Performance of bowel preparation quality scales in patients with Crohn's diseaseVirginia Solitano, Corey A Siegel, Joshua R Korzenik, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 12, 2013
Chemical and cytokine features of innate immunity characterize serum and tissue profiles in inflammatory bowel diseaseCharles G Knutson, Aswin Mangerich, Yu Zeng, et al.
International Journal of Hygiene and Environmental Health|September 2, 2018
Dibutyl-phthalate exposure from mesalamine medications and serum thyroid hormones in menFeiby L Nassan, Tim I M Korevaar, Brent A Coull, et al.
Inflammatory Bowel Diseases|August 20, 2015
Efficacy of Vedolizumab as Induction Therapy in Refractory IBD Patients: A Multicenter CohortEdward Shelton, Jessica R Allegretti, Betsy Stevens, et al.
Inflammatory Bowel Diseases|May 17, 2019
Challenges in IBD Research: Environmental TriggersShuk-Mei Ho, James D Lewis, Emeran A Mayer, et al.
Pageof 8